India  
 
NewsR.in

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Video Credit: ANI - Duration: 02:01s - Published
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.

A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management.

It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark.

India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year.

India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now.

This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Captain Sir Tom Moore's home up for sale

 The family home where Captain Sir Tom Moore raised millions for the NHS during the COVID pandemic by walking 100 laps of the garden is up for sale for £2.25m.
Sky News

WHO panel re-defines term airborne, 4 years after Covid controversy

 WHO consultation proposes 'through the air' descriptor for disease transmission, aiming to clarify pathogen transmission methods. Experts like Dr Neeraj Nischal..
IndiaTimes
These Foods Will Either Boost or Drain Your Energy [Video]

These Foods Will Either Boost or Drain Your Energy

These Foods Will Either Boost or Drain Your Energy. As the COVID-19 pandemic drags on, it can be a struggle to maintain consistent energy levels throughout the day. While a cup of coffee can provide a much-needed boost of energy, experts say eating the right food is actually a better option. . Here are 10 foods that'll either boost or drain your energy, according to three registered dietitian nutritionists. . 1. Black Beans (Energy Booster) . 2. Caffeine/Energy Drinks (Energy Drainer). 3. Bananas (Energy Booster). 4. Candy (Energy Drainer). 5. Eggs (Energy Booster). 6. Steak (Energy Drainer). 7. Water (Energy Booster). 8. Fruit Smoothies (Energy Drainer). 9. Pistachios (Energy Booster). 10. Low-Calorie Frozen Meals (Energy Drainer)

Credit: Wibbitz Top Stories    Duration: 01:30Published
US Life Expectancy on the Rise Following Pandemic Decline, CDC Report Says [Video]

US Life Expectancy on the Rise Following Pandemic Decline, CDC Report Says

US Life Expectancy on the Rise , Following Pandemic Decline, CDC Report Says. According to the latest federal mortality data, life expectancy in the United States increased in 2022. . The report published by the Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS) raised life expectancy to 77.5 years. The report published by the Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS) raised life expectancy to 77.5 years. The positive change comes after two years of decline following the pandemic. The positive change comes after two years of decline following the pandemic. While life expectancy has yet to reach pre-pandemic levels, 2022 showed an increase of 1.1 years compared to 2021. 2022 ended up recording 3.27 million deaths in the U.S., which was 184,374 fewer deaths than the year before. According to the report, heart disease and cancer remained the two most prevalent causes of death in the U.S. . According to the report, heart disease and cancer remained the two most prevalent causes of death in the U.S. . COVID-19 dropped to fourth on the list, and unintentional injuries took over the number three spot. COVID-19 dropped to fourth on the list, and unintentional injuries took over the number three spot. ABC reports that both males and females saw approximately the same increase in life expectancy from 2021 to 2022. Over the same period of time, the death rate decreased for nearly every age group. . Another NCHS report found that rates of drug overdose deaths from synthetic opioids increased by 4.1% between 2021 and 2022.

Credit: Wibbitz Top Stories    Duration: 01:30Published
German man vaccinated against Covid 217 times had no side-effects [Video]

German man vaccinated against Covid 217 times had no side-effects

Doctors report a man from Germany has been vaccinated 217 against the COVID-19 virus with no negative medical symptoms.

Credit: euronews (in English)    Duration: 00:35Published

Related videos from verified sources

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News [Video]

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News

Zydus Cadila's Virafin has been approved for emergency use to treat moderate Covid-19 patients by the drug controller general of india. How does Virafin work? #Virafin #ZydusCadila #CovidDrug

Credit: Oneindia     Duration: 01:24Published
Covid-19: Centre to fast-track emergency approval for vaccines| Oneindia News [Video]

Covid-19: Centre to fast-track emergency approval for vaccines| Oneindia News

The Centre has decided to fast-track emergency approval for COVID-19 vaccines uses in western nations and Japan after the world's biggest surge in cases in the country this month. In view of the rising..

Credit: Oneindia     Duration: 02:13Published
Vaccinations for 12 to 15-year-olds could be available in weeks [Video]

Vaccinations for 12 to 15-year-olds could be available in weeks

Local medical experts believe now that Pfizer has applied for Emergency Use Authorization for their COVID vaccine for those 12-15, that age group could be eligible for a vaccine by the end of the..

Credit: KMTV Action 3 News     Duration: 03:08Published